LEED Lab Buildings: Integrating New Workplace
Jay Shoemaker, AIA, Francis
Cauffman Foley Hoffmann Architects
The laboratory is the central and defining feature of wet or dry
research buildings. Their design, including all associated engineering
systems and material choices, has a significant influence on the
energy efficiency and environmental performance. However, from a
"whole building" perspective other aspects of the building's
design can also be substantial contributors. Given that a considerable
portion of each week day is spent on the job this presentation will
look at new thinking in the design of the research environments
intended to improve workplace efficiency and quality of experience.
(In some instances an investigation of efficiency, specifically
process and flow, has lead to a reduction is the size of the labs,
hence, a reduction in area requiring once-thru air.) Examples will
be shown of institutional, academic and corporate projects where
improvements in process, flow, natural light, views, material choices,
acoustics, etc. were embraced as meaningful and economical tools
to improve quality and efficiency.
Design can have a significant influence on people and the work
they do. Though difficult to measure, we have post occupancy and
anecdotal evidence from project completed and under construction
that considering what people do, how they relate, how they really
use space and what the space needs for provide, either as tools
or quality of environment, does have an impact on efficiency and
productivity both of research and facilities operations. Research
facility solutions that meet these criteria align with fundaments
of green architecture and engineering.
The approach, similar to my presentation at the Labs21 2003 Annual
Conference in Denver, will be based on project experience with lab
projects. In particular, the presentation addresses Human Factors,
such as, "Enabling better coordination between scientific staff
and facility operators and show improvements in user performance
Jay Shoemaker, AIA, is a Principal at Francis Cauffman Foley
Hoffmann, Architects Ltd., Philadelphia where he serves as the Director
of Science and Technology Group which does projects for academic,
institutional and pharmaceutical / biotechnology clients. His primary
responsibility is in laboratory planning, programming, and design.
He is currently working on several university projects and has led
strategic facilities planning initiatives and lab projects for Biogen,
Bristol-Myers Squibb, and Pfizer in the US and UK. Currently he
is responsible for the design of a Gold level research building.
Mr. Shoemaker has a Masters from Columbia University and a Bachelors
of Architecture and Fine Arts from Rhode Island School of Design;
he is also LEED accredited.
Back to the Agenda